By monitoring changes in circulating tumor DNA (ctDNA) among 30 patients treated with immunotherapies for metastatic non-small cell lung cancers, researchers were able to determine molecular response -- the clearance of tumor genetic material in the bloodstream.
Read more https://www.sciencedaily.com/releases/2023/12/231212131045.htm